Since the cytotoxicity was decreased by a larger gap in NBE U87 cells than in serum U87 cells after applying NKG2D blocking antibodies, the expression of causal NKG2D ligands and other K cell ligands on the tumor cell surfaces were explored. Here, KLRK1 is linked to neoplasm.